About Resergene
Resergene is a company based in Bengaluru (India) founded in 2014. Resergene offers products and services including Infalact and Accumaxe.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Resergene Biosciences Private Limited
- Date of Incorporation 02 Jun, 2014
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$6.71 K (USD)-96.78as on Mar 31, 2021
-
Net Profit
-$51.53 K (USD)-3311.82as on Mar 31, 2021
-
EBITDA
-$51.04 K (USD)-3576.15as on Mar 31, 2021
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resergene
Resergene offers a comprehensive portfolio of products and services, including Infalact and Accumaxe.
Infant milk formula is provided for nutritional support in early development stages.
Various formulations are offered for general health and specific conditions such as diabetes and cancer care.
Funding Insights of Resergene
Detailed funding history for Resergene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resergene
Investment portfolio details for Resergene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resergene
Detailed financials for Resergene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resergene Comparisons
Peer comparison for Resergene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resergene
Detailed competitors of Resergene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resergene
Complete news archive for Resergene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resergene
Resergene was founded in 2014.
Resergene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Annual revenue of Resergene is $6.71K as on Mar 31, 2021.
Resergene Biosciences is noted for its provision of nutrition-focused products, where infant milk formula like Infalact is supplied alongside clinical nutrition options such as Accumaxe and Nutriserge for general, maternal, child, gut, immunity, diabetes, critical, cancer, renal, hepatic, and obesity care. These products are designed to address various health needs, with an emphasis on comprehensive support through scientifically formulated diets. The companys operations are based in Bangalore, India, ensuring accessibility for health-related applications.
Resergene offers Infalact and Accumaxe.